NorthWest Biotherapeutics Inc (NWBO)

[cvmibelieve]

Some minority shareholders want the upcoming stockholder vote to be disregarded or discounted because they believe that a "for" vote to the 2018 Stock Options awards will cause some type of harm to the "company" by the majority shareholders and the minority shareholders want said ownership to be diluted. It appears the board wants to maintain a specific share percentage of executive ownership (perhaps to ward off hostile investors). It is unknown what is the minority shareholder's true intent, if it's genuine or if they represent a malicious third party's interest

During the past 15 years the NWBO executive team has been working on behalf of shareholders to bring this PH3 trial and treatment to patients. No revenues except for financing. They have resisted hostile investors, bad financing deals, illegal spoofing, malicious lawsuits, FTD shorts with a bankrupt agenda, activist investors, and the Big Pharma Mafia. The NWBO board believes the stock options are warranted because of: “the extent of personal and professional risk [the] independent directors have endured in serving on our Board.”

They have now delivered a successful PH3 trial, prestigious JAMA peer Review. The company is now at a significantly de-risked junction. If you believe the current executive team can take the company to the revenue stage and unlock the stock price and the true company value... then proxy "for"